Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Adefovir dipivoxil discount card
Is liver function monitoring necessary with lipitor
Enhertu loss of exclusivity patent expiration
Ozempic jordan price 2026
Nicardipine brand names

Jatenzo availability in china?

See the DrugPatentWatch profile for Jatenzo

Jatenzo (raltegravir‑ritonavir) – Availability in China

Topic Information
Current regulatory status As of the latest updates (2024‑2026), Jatenzo has not been approved by the China Food and Drug Administration (CFDA, now NMPA) for use in the Chinese market. The drug remains licensed only in the United States and a handful of other countries.
Why it’s not yet available 1. Approval process: Each country has its own clinical‑trial and data‑submission requirements. Jatenzo’s manufacturer has not submitted a dossier to the NMPA.
2. Market demand & competition: China already has several well‑established integrase inhibitors (e.g., dolutegravir, bictegravir, elvitegravir/ cobicistat, and the newer cabotegravir) that cover the therapeutic niche Jatenzo targets.
3. Supply chain & formulation issues: The ritonavir‑boosted formulation requires specific excipients and quality‑control steps that may not have been fully aligned with local manufacturing standards yet.
Alternatives available in China • Dolutegravir (Tivicay®/Tivicay®) – widely prescribed.
• Bictegravir (Biktarvy®) – approved in China (2022).
• Elvitegravir/Cobicistat (Vitekta®) – also approved.
• Cabotegravir (Cabenuva®) – recently approved for long‑acting injectable therapy.
• Other generics: several Chinese manufacturers produce generic raltegravir, but without ritonavir boosting (so not identical to Jatenzo).
What to do if you need Jatenzo 1. Consult a healthcare provider. A specialist can assess whether a different integrase inhibitor is suitable for your regimen.
2. Check for clinical trials. Occasionally, multinational pharmaceutical companies run trials in China that might offer access to investigational drugs—though these are usually limited to specific patient populations.
3. Importation (special‑purpose/medical export). Some pharmacies and medical export services can import drugs from the U.S. under special regulations (e.g., for patients with a prescription from a licensed Chinese doctor). However, this route is costly, time‑consuming, and subject to customs inspection.
Key points for patients • Adherence and monitoring: Regardless of which integrase inhibitor you take, consistent dosing and viral‑load monitoring are essential.
• Drug–drug interactions: Ritonavir boosting can affect metabolism of other drugs. If you are on other medications (antifungals, anti‑epileptics, etc.), discuss potential interactions with your prescriber.
• Cost considerations: Generic integrase inhibitors are available at lower prices in China compared to branded Jatenzo (which, if available, would be very expensive).

Bottom line

  • Jatenzo is not currently approved for or sold in China.
  • You can use other approved integrase inhibitors in China that provide similar therapeutic benefits.
  • If you have a strong clinical reason for Jatenzo, talk to your HIV specialist about alternatives or potential trial opportunities.

Feel free to ask if you need help comparing specific integrase inhibitors or guidance on how to obtain a prescription in China.



Other Questions About Jatenzo :

Jatenzo capsules price? Jatenzo (testosterone undecanoate) drug profile, 2024? Fda approval dates jatenzo kyzatrex tlando? Jatenzo buy online? Jatenzo fda approval? How much does jatenzo cost? Jatenzo precio?